{
    "root": "35d2e40e-8eee-ef2d-e063-6294a90aadc0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution",
    "value": "20250523",
    "ingredients": [
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SACCHARIN SODIUM",
            "code": "SB8ZUX40TY"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU"
        },
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "ASCORBIC ACID",
            "code": "PQ6CK8PD0R"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "MENTHOL, UNSPECIFIED FORM",
            "code": "L7T10EIP3A"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "DEXTROMETHORPHAN HYDROBROMIDE",
            "code": "9D2RTI9KYH"
        },
        {
            "name": "PROMETHAZINE HYDROCHLORIDE",
            "code": "R61ZEH7I1I"
        }
    ],
    "indications": "Promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold.",
    "contraindications": "Promethazine hydrochloride and dextromethorphan hydrobromide oral solution is contraindicated for children under 2 years of age(see\n \n  \n                        WARNINGS– Black Box Warning\n \n  and\n \n  \n                        Use In Pediatric Patients\n                     ).\n\n \n                  The average effective dose is given in the following table:\n                  \n                     \n                     \n                     \n                        \n                           \n                              Adults\n                           \n                           \n                              1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 30 mL in 24 hours.\n                           \n                        \n                        \n                           \n                              Children 6 Years To Under 12 Years\n                           \n                           \n                              ½ to 1 teaspoonful (2.5 to 5 mL) every 4 to 6 hours, not to exceed 20 mL in 24 hours.\n                           \n                        \n                        \n                           \n                              Children 2 Years To Under 6 Years\n                           \n                           \n                              ¼ to ½ teaspoonful (1.25 to 2.5 mL) every 4 to 6 hours,\n                              not to exceed 10 mL in 24 hours.",
    "warningsAndPrecautions": "This preparation is a clear oral solution with yellow color and pineapple menthol odor, containing promethazine hydrochloride 6.25 mg/5 mL, dextromethorphan hydrobromide 15 mg/5 mL and alcohol 7 percent, and is available in NDC 17856-0155-01  PROMETHAZINE (with DM) 15-6.25/5 - 5 ML CUP 72 ct UD\n                  Keep tightly closed. Protect from light.\n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP.\n                  \n                  \n                  Distributed by:\n                  ATLANTIC BIOLOGICALS CORP.\n                  MIAMI, FL 33179",
    "adverseReactions": "Dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (MAOI) (see\n \n  PRECAUTIONS,\n \n  Drug Interactions).\n\n \n                  Promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines.\n                  Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma."
}